Literature DB >> 25084173

Interferons, signal transduction pathways, and the central nervous system.

Shreeram C Nallar1, Dhan V Kalvakolanu.   

Abstract

The interferon (IFN) family of cytokines participates in the development of innate and acquired immune defenses against various pathogens and pathogenic stimuli. Discovered originally as a proteinaceous substance secreted from virus-infected cells that afforded immunity to neighboring cells from virus infection, these cytokines are now implicated in various human pathologies, including control of tumor development, cell differentiation, and autoimmunity. It is now believed that the IFN system (IFN genes and the genes induced by them, and the factors that regulate these processes) is a generalized alarm of cellular stress, including DNA damage. IFNs exert both beneficial and deleterious effects on the central nervous system (CNS). Our knowledge of the IFN-regulated processes in the CNS is far from being clear. In this article, we reviewed the current understanding of IFN signal transduction pathways and gene products that might have potential relevance to diseases of the CNS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25084173      PMCID: PMC4118707          DOI: 10.1089/jir.2014.0021

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  197 in total

Review 1.  A weak signal for strong responses: interferon-alpha/beta revisited.

Authors:  T Taniguchi; A Takaoka
Journal:  Nat Rev Mol Cell Biol       Date:  2001-05       Impact factor: 94.444

Review 2.  Alternate interferon signaling pathways.

Authors:  Dhananjaya V Kalvakolanu
Journal:  Pharmacol Ther       Date:  2003-10       Impact factor: 12.310

3.  The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta.

Authors:  Peter Härle; Bruno Sainz; Daniel J J Carr; William P Halford
Journal:  Virology       Date:  2002-02-15       Impact factor: 3.616

4.  Innate STAT1-dependent genomic response of neurons to the antiviral cytokine alpha interferon.

Authors:  Jianping Wang; Iain L Campbell
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development.

Authors:  J G Corbin; D Kelly; E M Rath; K D Baerwald; K Suzuki; B Popko
Journal:  Mol Cell Neurosci       Date:  1996-05       Impact factor: 4.314

6.  Connexins are critical for normal myelination in the CNS.

Authors:  Daniela M Menichella; Daniel A Goodenough; Erich Sirkowski; Steven S Scherer; David L Paul
Journal:  J Neurosci       Date:  2003-07-02       Impact factor: 6.167

7.  Vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, and noradrenaline induce the transcription factors CCAAT/enhancer binding protein (C/EBP)-beta and C/EBP delta in mouse cortical astrocytes: involvement in cAMP-regulated glycogen metabolism.

Authors:  J R Cardinaux; P J Magistretti
Journal:  J Neurosci       Date:  1996-02-01       Impact factor: 6.167

8.  Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1.

Authors:  L I Bruijn; M K Houseweart; S Kato; K L Anderson; S D Anderson; E Ohama; A G Reaume; R W Scott; D W Cleveland
Journal:  Science       Date:  1998-09-18       Impact factor: 47.728

9.  Monoallelic loss of tumor suppressor GRIM-19 promotes tumorigenesis in mice.

Authors:  Sudhakar Kalakonda; Shreeram C Nallar; Sausan Jaber; Susan K Keay; Ellen Rorke; Raghava Munivenkatappa; Daniel J Lindner; Gary M Fiskum; Dhananjaya V Kalvakolanu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-21       Impact factor: 11.205

10.  Trex1 prevents cell-intrinsic initiation of autoimmunity.

Authors:  Daniel B Stetson; Joan S Ko; Thierry Heidmann; Ruslan Medzhitov
Journal:  Cell       Date:  2008-08-22       Impact factor: 41.582

View more
  13 in total

Review 1.  Ethanol and Cytokines in the Central Nervous System.

Authors:  Marisa Roberto; Reesha R Patel; Michal Bajo
Journal:  Handb Exp Pharmacol       Date:  2018

Review 2.  Taking the road less traveled - the therapeutic potential of CBP/β-catenin antagonists.

Authors:  Michael Kahn
Journal:  Expert Opin Ther Targets       Date:  2021-10-27       Impact factor: 6.902

3.  Effect of interferon-β1b on CXCR4-dependent chemotaxis in T cells from multiple sclerosis patients.

Authors:  T Wostradowski; V Gudi; R Pul; S Gingele; J A Lindquist; M Stangel; S Lindquist
Journal:  Clin Exp Immunol       Date:  2015-08-31       Impact factor: 4.330

4.  Gene-Expression Profiling Suggests Impaired Signaling via the Interferon Pathway in Cstb-/- Microglia.

Authors:  Inken Körber; Shintaro Katayama; Elisabet Einarsdottir; Kaarel Krjutškov; Paula Hakala; Juha Kere; Anna-Elina Lehesjoki; Tarja Joensuu
Journal:  PLoS One       Date:  2016-06-29       Impact factor: 3.240

5.  Goose Mx and OASL Play Vital Roles in the Antiviral Effects of Type I, II, and III Interferon against Newly Emerging Avian Flavivirus.

Authors:  Shun Chen; Wei Zhang; Zhen Wu; Jinyue Zhang; Mingshu Wang; Renyong Jia; Dekang Zhu; Mafeng Liu; Kunfeng Sun; Qiao Yang; Ying Wu; Xiaoyue Chen; Anchun Cheng
Journal:  Front Immunol       Date:  2017-08-23       Impact factor: 7.561

Review 6.  Advances in the treatment of relapsing-remitting multiple sclerosis: the role of pegylated interferon β-1a.

Authors:  Kendra L Furber; Marina Van Agten; Charity Evans; Azita Haddadi; J Ronald Doucette; Adil J Nazarali
Journal:  Degener Neurol Neuromuscul Dis       Date:  2017-03-24

Review 7.  Therapeutic spectrum of interferon-β in ischemic stroke.

Authors:  Madhuri Wanve; Harpreet Kaur; Deepaneeta Sarmah; Jackson Saraf; Kanta Pravalika; Kanchan Vats; Kiran Kalia; Anupom Borah; Dileep R Yavagal; Kunjan R Dave; Pallab Bhattacharya
Journal:  J Neurosci Res       Date:  2018-10-15       Impact factor: 4.164

8.  Human iPSC-Derived Neuronal Cells From CTBP1-Mutated Patients Reveal Altered Expression of Neurodevelopmental Gene Networks.

Authors:  S Vijayalingam; Uthayashanker R Ezekiel; Fenglian Xu; T Subramanian; Elizabeth Geerling; Brittany Hoelscher; KayKay San; Aravinda Ganapathy; Kyle Pemberton; Eric Tycksen; Amelia K Pinto; James D Brien; David B Beck; Wendy K Chung; Christina A Gurnett; G Chinnadurai
Journal:  Front Neurosci       Date:  2020-10-27       Impact factor: 4.677

9.  Regulation of IFN-Is by MEF2D Promotes Inflammatory Homeostasis in Microglia.

Authors:  Fangfang Lu; Ronglin Wang; Li Xia; Tiejian Nie; Fei Gao; Shaosong Yang; Lu Huang; Kaifeng Shao; Jiankang Liu; Qian Yang
Journal:  J Inflamm Res       Date:  2021-06-29

10.  Caspase-Dependent Cleavage of DDX21 Suppresses Host Innate Immunity.

Authors:  Wei Wu; Yang Qu; Shengqing Yu; Sa Wang; Yuncong Yin; Qinfang Liu; Chunchun Meng; Ying Liao; Zaib Ur Rehman; Lei Tan; Cuiping Song; Xusheng Qiu; Weiwei Liu; Chan Ding; Yingjie Sun
Journal:  mBio       Date:  2021-06-14       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.